But there was no smell of op poisoning
The absence of a characteristic smell does not rule out organophosphate (OP) poisoning. Here's why:
Not all OPs have a strong odor. The classic "garlic-like" or "kerosene-like" smell is associated with certain OP compounds (e.g., parathion, malathion), but many modern or purified formulations are odorless or nearly odorless. Sarin (GB), for example, is essentially colorless and odorless.
Key clinical points:
- Diagnosis of OP poisoning is clinical, based on the toxidrome - not smell
- The toxidrome is driven by acetylcholinesterase inhibition, causing excess acetylcholine at muscarinic and nicotinic receptors
- Smell is an unreliable diagnostic feature and should never be used to exclude the diagnosis
What to look for instead (the cholinergic toxidrome):
| System | Features |
|---|---|
| Muscarinic (SLUDGE/DUMBELS) | Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis; Bradycardia, Bronchospasm, Miosis |
| Nicotinic | Muscle fasciculations, weakness, paralysis, tachycardia (can mask bradycardia) |
| CNS | Anxiety, seizures, coma |
Confirmatory tests:
- Serum/plasma butyrylcholinesterase (pseudocholinesterase) - faster, more sensitive
- RBC acetylcholinesterase - more specific but slower
Bottom line: If the clinical picture fits OP poisoning (miosis, bronchospasm, bradycardia, secretions, fasciculations), treat empirically with atropine + pralidoxime (2-PAM). Do not withhold treatment because there is no smell.
atropine vs adrenaline
Both are used in emergencies but work through completely different mechanisms. Here's a direct comparison:
Atropine vs Adrenaline (Epinephrine)
| Feature | Atropine | Adrenaline (Epinephrine) |
|---|---|---|
| Drug class | Anticholinergic (muscarinic antagonist) | Sympathomimetic (α + β agonist) |
| Mechanism | Blocks ACh at muscarinic receptors | Directly stimulates adrenergic receptors |
| Heart rate | ↑ (blocks vagal slowing) | ↑ (β1 agonism) |
| BP | Mild ↑ | ↑↑ (α1 vasoconstriction + β1 inotropy) |
| Bronchi | Bronchodilation (blocks M3) | Bronchodilation (β2 agonism) |
| Secretions | ↓↓ Dries secretions | No major effect |
| Pupils | Mydriasis (dilates) | Mydriasis (α1) |
When to use which:
Atropine is first-line for:
- OP/carbamate poisoning - counters excess ACh (bradycardia, bronchospasm, secretions)
- Symptomatic bradycardia (sinus, AV block)
- Pre-anesthetic - reduces secretions
- Organophosphate-induced bronchospasm
- Vagally-mediated events (vasovagal syncope)
Adrenaline is first-line for:
- Anaphylaxis - only drug that addresses all components (bronchospasm + hypotension + angioedema)
- Cardiac arrest (VF, PEA, asystole) - in ACLS protocol
- Severe asthma (IM/SC when β2 inhaler fails)
- Croup (nebulized racemic epinephrine)
Critical distinction in OP poisoning context:
In OP poisoning, atropine is the antidote - it specifically counters the muscarinic excess. Adrenaline would NOT help with bronchospasm from OP poisoning because the problem is not mast cell degranulation - it is excess ACh at M3 receptors, which only an anticholinergic can block.
Conversely, in anaphylaxis, atropine alone would be inadequate - you need adrenaline to reverse mast-cell-mediated bronchospasm, vasodilation, and angioedema.
Memory tip:
- Atropine = blocks parasympathetic overstimulation
- Adrenaline = mimics sympathetic activation
They can occasionally be used together (e.g., atropine for bradycardia refractory to adrenaline in some arrest protocols), but their primary indications are distinct.
This is a shared conversation. Sign in to Orris to start your own chat.